FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ben Venue Laboratories CYTARAbine for Injection Recall

CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distr…

Ben Venue Laboratories Inc · Bedford, OH

Risk level
Class II
Reported by FDA
Aug 27, 2014
Recall ID
D-1543-2014
Check your lot numberHow we source this data

Summary

Ben Venue Laboratories recalled CYTARAbine for Injection starting Jul 31, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1543-2014 on Aug 27, 2014. Reason: Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.

Product description

CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01

Lot numbers, UPCs & expiration codes

Lot # 0161-13-2167551; Exp. 07/14 Lot # 0161-13-2176919; Exp. 08/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1543-2014
Classification
Class II
Status
Terminated
Recall initiated
Jul 31, 2014
FDA report date
Aug 27, 2014
Quantity
7172 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Ben Venue Laboratories Inc

Original FDA data

Every field from FDA enforcement report D-1543-2014, exactly as published.

Show all FDA fields
City
Bedford
State
OH
Status
Terminated
Country
United States
Event ID
68800
Address
300 Northfield Rd
Code information
Lot # 0161-13-2167551; Exp. 07/14 Lot # 0161-13-2176919; Exp. 08/14
Postal code
44146-4650
Report date
Aug 27, 2014
Product type
Drugs
Recall number
D-1543-2014
Classification
Class II
Recalling firm
Ben Venue Laboratories Inc
Product quantity
7172 vials
Termination date
Dec 2, 2014
Reason for recall
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01
Distribution pattern
Nationwide
Recall initiation date
Jul 31, 2014
Initial firm notification
Letter
Center classification date
Aug 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1543-2014, published Aug 27, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls